Jaguar Health explores strategic alternatives amid rare disease NDA push
Jaguar Health, Inc. (NASDAQ: JAGX) said its Board of Directors has begun a process to explore strategic alternatives, including potential ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
